The Prescription Monitoring Act, which enables the collection, use and dissemination of information related to monitored drugs, requires the Minister of Health to conduct a comprehensive review of the operation of the Act four years after coming into force.
Input from stakeholders and the general public is important to the success of this review.
A discussion paper was developed to provide background information on the Prescription Monitoring Act, its operation since the Act came into force, and provide areas of improvement for consideration by examining aspects of the Act that have been the subject of discussions over the past four years.
The Prescription Monitoring Act can be consulted online on the Government of New Brunswick website. The regulations which support the Act can also be found online.
All New Brunswickers are welcome to submit comments and suggestions in response to the discussion paper.
Submissions on this review can be sent electronically or through regular mail.
Electronic submissions can be sent by e-mail to: [email protected]
Submissions by regular mail can be sent to:
Prescription Monitoring Act Legislative Review
New Brunswick Department of Health
P.O. Box 5100
Fredericton, New Brunswick
E3B 5H1
All submissions should be received by: 17/06/2019